As per WHO: “Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or...
Sep. 10, 2020: "Sol-Gel Technologies, a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment...
September 10, 2020: "The U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids...
September 10, 2020: "AstraZeneca announced that it will be transferring the listing of its American Depositary Receipts (ADRs) and its US-listed debt securities from...
Pfizer and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which...
Sep. 10, 2020: "The FDA has approved a new indication for GlaxoSmithKline and Innoviva's Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of...
September 09, 2020: "ATDBio, a leader in complex oligonucleotide synthesis, and a research team at the Botnar Research Centre, University of Oxford, have been awarded...
September 09, 2020: "Bristol Myers Squibb announced that the U.S.FDA has approved Onureg® (azacitidine 300 mg tablets, CC-486) for the continued treatment of adult patients with...
Sept. 08, 2020:Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of a pilot study to investigate the efficacy and...
September 04, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
The FDA issued...
September 07, 2020: "The Russian Direct Investment Fund (RDIF) and the Gamaleya National Research Center of Epidemiology and Microbiology have reported positive early results...